Literature DB >> 12506785

Esthetic aspects of orthodontic-surgical treatment of sagittal-vertical anomalies: the example of the short face syndrome.

Nezar Watted1, Axel Bartsch.   

Abstract

BACKGROUND: Psycho-esthetic aspects play an important role in motivating patients to undergo combined orthodontic-surgical treatment as well as in the subjective appraisal of treatment outcome. The facial soft tissues are the crucial interlink between the underlying skeletal and dental structures and their perception by the patient and his social environment. TREATMENT OF SHORT FACE SYNDROME: In the therapy of Class II malocclusions with skeletal deep bite and short lower face (short face syndrome), the soft tissues and the psycho-esthetic treatment expectations of the patient are taken systematically and appropriately into account during treatment planning and evaluation. PATIENTS AND
METHOD: The respective elements of the treatment concept are outlined and explained in this article. Based on the empirical evaluation of 15 patients treated according to this concept, the soft tissue changes in patients with short face syndrome and the changes in esthetic and psychosocial self-perception are reported.
RESULTS: The results demonstrate the efficiency of the treatment concept in improving facial soft tissues, especially in the vertical dimension, and the resulting psycho-esthetic benefit to the patient.

Entities:  

Mesh:

Year:  2002        PMID: 12506785     DOI: 10.1007/s00056-002-0017-5

Source DB:  PubMed          Journal:  J Orofac Orthop        ISSN: 1434-5293            Impact factor:   1.938


  2 in total

1.  Do Specific Craniomaxillofacial Features Correlate with Psychological Distress in Adult Pretreatment Orthodontic Patients? A Cephalometric Study.

Authors:  Chu-Qiao Xiao; Yi-Dan Wan; Zhe-Bin Yan; Ya-Qi Li; Pei-Di Fan; Qiao-Yu Cheng; Xin Xiong
Journal:  Dis Markers       Date:  2022-05-05       Impact factor: 3.464

2.  The Influence of the Smile on the Perceived Facial Type Esthetics.

Authors:  Waeil Batwa
Journal:  Biomed Res Int       Date:  2018-07-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.